Still, the company said studies show a booster dose increases protection equivalent to the 94% efficacy shown by the Moderna and Pfizer mRNA vaccines soon after they were first given in clinical trials last year.Meanwhile, various real-world studies suggest that Johnson & Johnson's vaccine was anywhere between 50% and 68% effective, Dr.But a study published Thursday reported a steep decline in vaccine effectiveness against infection by August of this year, especially for people who received the J&J vaccine.Researchers found that among more than 600,000 veterans, J&J's vaccine's protection against infection fell from 88% in March to 3% in August.The FDA vaccine advisory committee also supported emergency use authorization for booster shots of Moderna's Covid-19 vaccine after six months, but not for everyone.
Not quite yet," Schaffner said.Black people represent a larger share of new vaccinations As public health officials talk boosters, 66 million Americans who are eligible for a vaccine still haven't received their initial shots, while nearly 57% of the US population is fully vaccinated, according to the CDC.Black and brown communities have proven to be disproportionally bearing the brunt of the pandemic for various reasons, including health care inequities.Another analysis published earlier this month by the Kaiser Family Foundation (KFF) showed the difference in Covid-19 cases and deaths between Black, Hispanic and White people is narrowing.KFF researchers found that while disparities are still present across different racial groups, the gap is improving for Black and Hispanic people, based on an analysis of case and death data from CDC last month.
16 hours ago
17 hours ago
19 hours ago
19 hours ago
Get monthly updates and free resources.
CONNECT WITH US